Walleye Trading
TBPH icon

Walleye Trading’s Theravance Biopharma TBPH Stock Holding History

Walleye Trading’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$104K – 5347
2023
Q2 		$104K Hold
10,000
– – ﹤0.01% 3730
2023
Q1 		$109K Buy
+10,000
New +$106K ﹤0.01% 3820
2022
Q4 		– Sell
-19,200
Closed -$195K – 5409
2022
Q3 		$195K Buy
+19,200
New +$180K ﹤0.01% 3693

Other funds holding TBPH

WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Walleye Trading's TBPH Position: Q3 2022 in Review

Walleye Trading sold out of Theravance Biopharma (TBPH) in Q3 2022, closing a stake of 14,475 shares — an estimated $136K sold.

Walleye Trading first reported a position in TBPH in Q2 2016 and held it in 3 quarters. The position peaked at $131K in Q2 2022. 123 funds tracked by Wall St. Rank hold TBPH as of Q3 2022.

  • Walleye Trading reported no remaining Theravance Biopharma position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 14,475 Theravance Biopharma shares in Q3 2022, an estimated $136K.
  • Walleye Trading first reported a position in Theravance Biopharma in Q2 2016 and held it in 3 quarters.
  • Walleye Trading's Theravance Biopharma position peaked at $131K in Q2 2022.
  • 123 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.